Filter
75
Text search:
MRSA
Featured
Recommendations
7
New Publications
10
Language
Document type
Studies & Reports
30
Guidelines
20
No document type
13
Fact sheets
5
Manuals
3
Strategic & Response Plan
3
Brochures
1
Countries / Regions
India
4
Germany
3
Western and Central Europe
3
Ethiopia
2
Syria
2
Kenya
2
Tanzania
2
South Africa
2
Nigeria
1
Senegal
1
Ghana
1
Zimbabwe
1
Philippines
1
Pakistan
1
South Sudan
1
Jordan
1
Thailand
1
Indonesia
1
Argentina
1
Namibia
1
El Salvador
1
Bolivia
1
Myanmar / Burma
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Africa
1
Global
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
22
Key Resources
5
Clinical Guidelines
3
Pharmacy & Technologies
2
Women & Child Health
1
Toolboxes
AMR
45
COVID-19
6
Refugee
4
Caregiver
4
Planetary Health
4
TB
3
2.0 Rapid Response
3
Ebola & Marburg
2
Rapid Response
2
HIV
1
Mental Health
1
Specific Hazards
1
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us
...
In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance, and with standards and
...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c
...
Health care-associated infections (HAI) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. At any one time, up to 7% of patients in developed and 10% in developing countries will acquire at least on
...
The checklist tool described in this handbook is intended for EU/EEA public health authorities who need to assess the capacity for communicable disease prevention and control at migrant reception/detention centres hosting migrants for weeks/months (medium-term) in order to identify gaps and set prio
...
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de
...
Monatsschrift Kinderheilkunde December 2015, Volume 163, Issü 12, pp 1269-1286.
Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie, der Gesellschaft für Tropenpädiatrie und Internationale Kindergesundheit und des Berufsverbandes der Kinder- und Jugendärzte